Reports that Vytorin is no more effective than generic drugs in battling cholesterol have already generated lawsuits. The suits claim drug makers Merck & Co. Inc. and Schering-Plough Corp. delayed release of the negative study while touting the drug’s benefits, the National Law Journal reports. Lawyer Steve Berman of Seattle…
Jan 28, 2008 12:28 PM CST